← Eichor
Study identifier: NCT02530073 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

Condition: Congenital Diaphragmatic Hernias  ·  Sponsor: Connecticut Children's Medical Center

PhaseNA
Planned participants15
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore adequate lung growth for neonatal survival.

This description comes directly from the study's public registry record.

Talk to the study team

Katie E Boyle, MPH  ·  860-837-6547  ·  Kboyle01@connecticutchildrens.org

Always discuss trial participation with your own doctor first.

Locations (1)

Connecticut Children's Medical CenterHartford, Connecticut, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02530073